Functional modulation of AMP-activated protein kinase by cereblon

Biochim Biophys Acta. 2011 Mar;1813(3):448-55. doi: 10.1016/j.bbamcr.2011.01.005. Epub 2011 Jan 11.

Abstract

Mutations in cereblon (CRBN), a substrate binding component of the E3 ubiquitin ligase complex, cause a form of mental retardation in humans. However, the cellular proteins that interact with CRBN remain largely unknown. Here, we report that CRBN directly interacts with the α1 subunit of AMP-activated protein kinase (AMPK α1) and inhibits the activation of AMPK activation. The ectopic expression of CRBN reduces phosphorylation of AMPK α1 and, thus, inhibits the enzyme in a nutrient-independent manner. Moreover, AMPK α1 can be potently activated by suppressing endogenous CRBN using CRBN-specific small hairpin RNAs. Thus, CRBN may act as a negative modulator of the AMPK signaling pathway in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / genetics
  • AMP-Activated Protein Kinases / metabolism*
  • ATP-Dependent Proteases
  • Adaptor Proteins, Signal Transducing
  • Animals
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism*
  • Cell Line
  • DNA, Complementary / genetics
  • Enzyme Activation
  • Gene Expression Regulation
  • Humans
  • Mice
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism*
  • Peptide Hydrolases / genetics
  • Peptide Hydrolases / metabolism*
  • Protein Binding
  • Rats
  • Ubiquitin-Protein Ligase Complexes
  • Ubiquitin-Protein Ligases

Substances

  • Adaptor Proteins, Signal Transducing
  • CRBN protein, human
  • CRBN protein, rat
  • Carrier Proteins
  • Crbn protein, mouse
  • DNA, Complementary
  • Nerve Tissue Proteins
  • Ubiquitin-Protein Ligase Complexes
  • Ubiquitin-Protein Ligases
  • AMP-Activated Protein Kinases
  • Peptide Hydrolases
  • ATP-Dependent Proteases